Some history for you young un's and a little more background on the possible doping relationships in U.S. Pro Cycling in the late-eighties early-nineties.
Article breezes over the Wiesel/Eddie B. [cough]doper![cough] relationship and Weisel's funding Amgen pre-IPO. Hindsight being 20/20 and all, the three come together rather elegantly to make a fine doping system.
Amgen has a long interconnected involvement with cycling. Beyond the sponsorship of the Tour of California,... The history of Epogen has been one filled with question marks involving the potential use of those specific products by the PDM team in 1990 that led to several high-profile deaths. Could the alleged experimental use of Epogen by cycling teams in the late 80s and early 90s be interpreted as a “field study” of the drug and its applications? The former doctor of the PDM team, Wim Sanders, had been investigated in the Netherlands in the late 1990s, and the name of both the company and its product surfaced during that investigation, which indicates the answer to the question could be yes.
And then there's this relationship that hasn't ever been fully investigated.
Weisel’s Montgomery Securities had financial relationships with other firms in the biotechnology sector, including 5am Ventures, the company that in 2002 brought together as its managing partners Andrew Schwab, a former VP at Montgomery Securities, and Scott Rocklage, a former CEO of Nycomed Salutar. This interesting connection has significance to cycling, as the US Postal team was revealed by French journalists to be using Actovegin, a Nycomed product, when US Postal employees carelessly dumped trash during the 2000 Tour de France.
IMHO, there are lots of unexplored and totally legitimate allegations in this article. It's old news though...
http://cyclismas.com/2011/11/the-tr...-that-shaped-u-s-cycling-in-the-armstrong-era
Article breezes over the Wiesel/Eddie B. [cough]doper![cough] relationship and Weisel's funding Amgen pre-IPO. Hindsight being 20/20 and all, the three come together rather elegantly to make a fine doping system.
Amgen has a long interconnected involvement with cycling. Beyond the sponsorship of the Tour of California,... The history of Epogen has been one filled with question marks involving the potential use of those specific products by the PDM team in 1990 that led to several high-profile deaths. Could the alleged experimental use of Epogen by cycling teams in the late 80s and early 90s be interpreted as a “field study” of the drug and its applications? The former doctor of the PDM team, Wim Sanders, had been investigated in the Netherlands in the late 1990s, and the name of both the company and its product surfaced during that investigation, which indicates the answer to the question could be yes.
And then there's this relationship that hasn't ever been fully investigated.
Weisel’s Montgomery Securities had financial relationships with other firms in the biotechnology sector, including 5am Ventures, the company that in 2002 brought together as its managing partners Andrew Schwab, a former VP at Montgomery Securities, and Scott Rocklage, a former CEO of Nycomed Salutar. This interesting connection has significance to cycling, as the US Postal team was revealed by French journalists to be using Actovegin, a Nycomed product, when US Postal employees carelessly dumped trash during the 2000 Tour de France.
IMHO, there are lots of unexplored and totally legitimate allegations in this article. It's old news though...
http://cyclismas.com/2011/11/the-tr...-that-shaped-u-s-cycling-in-the-armstrong-era